IBDEI2FP ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41289,1,3,0)
 ;;=3^Liver Cell Carcinoma
 ;;^UTILITY(U,$J,358.3,41289,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,41289,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,41290,0)
 ;;=D05.02^^159^2004^98
 ;;^UTILITY(U,$J,358.3,41290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41290,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,41290,1,4,0)
 ;;=4^D05.02
 ;;^UTILITY(U,$J,358.3,41290,2)
 ;;=^5001928
 ;;^UTILITY(U,$J,358.3,41291,0)
 ;;=D05.01^^159^2004^99
 ;;^UTILITY(U,$J,358.3,41291,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41291,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,41291,1,4,0)
 ;;=4^D05.01
 ;;^UTILITY(U,$J,358.3,41291,2)
 ;;=^5001927
 ;;^UTILITY(U,$J,358.3,41292,0)
 ;;=D05.00^^159^2004^100
 ;;^UTILITY(U,$J,358.3,41292,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41292,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Unspec Breast
 ;;^UTILITY(U,$J,358.3,41292,1,4,0)
 ;;=4^D05.00
 ;;^UTILITY(U,$J,358.3,41292,2)
 ;;=^5001926
 ;;^UTILITY(U,$J,358.3,41293,0)
 ;;=R59.0^^159^2004^61
 ;;^UTILITY(U,$J,358.3,41293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41293,1,3,0)
 ;;=3^Enlarged Lymph Nodes,Localized
 ;;^UTILITY(U,$J,358.3,41293,1,4,0)
 ;;=4^R59.0
 ;;^UTILITY(U,$J,358.3,41293,2)
 ;;=^5019529
 ;;^UTILITY(U,$J,358.3,41294,0)
 ;;=C83.59^^159^2004^101
 ;;^UTILITY(U,$J,358.3,41294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41294,1,3,0)
 ;;=3^Lymphoblastic Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,41294,1,4,0)
 ;;=4^C83.59
 ;;^UTILITY(U,$J,358.3,41294,2)
 ;;=^5001590
 ;;^UTILITY(U,$J,358.3,41295,0)
 ;;=C83.50^^159^2004^102
 ;;^UTILITY(U,$J,358.3,41295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41295,1,3,0)
 ;;=3^Lymphoblastic Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,41295,1,4,0)
 ;;=4^C83.50
 ;;^UTILITY(U,$J,358.3,41295,2)
 ;;=^5001581
 ;;^UTILITY(U,$J,358.3,41296,0)
 ;;=C43.9^^159^2004^104
 ;;^UTILITY(U,$J,358.3,41296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41296,1,3,0)
 ;;=3^Malig Melanoma of Skin,Unspec Site
 ;;^UTILITY(U,$J,358.3,41296,1,4,0)
 ;;=4^C43.9
 ;;^UTILITY(U,$J,358.3,41296,2)
 ;;=^5001015
 ;;^UTILITY(U,$J,358.3,41297,0)
 ;;=C31.9^^159^2004^105
 ;;^UTILITY(U,$J,358.3,41297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41297,1,3,0)
 ;;=3^Malig Neop Accessory Sinus,Unspec
 ;;^UTILITY(U,$J,358.3,41297,1,4,0)
 ;;=4^C31.9
 ;;^UTILITY(U,$J,358.3,41297,2)
 ;;=^5000953
 ;;^UTILITY(U,$J,358.3,41298,0)
 ;;=C24.1^^159^2004^107
 ;;^UTILITY(U,$J,358.3,41298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41298,1,3,0)
 ;;=3^Malig Neop Ampulla of Vater
 ;;^UTILITY(U,$J,358.3,41298,1,4,0)
 ;;=4^C24.1
 ;;^UTILITY(U,$J,358.3,41298,2)
 ;;=^267100
 ;;^UTILITY(U,$J,358.3,41299,0)
 ;;=C21.0^^159^2004^108
 ;;^UTILITY(U,$J,358.3,41299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41299,1,3,0)
 ;;=3^Malig Neop Anus,Unspec
 ;;^UTILITY(U,$J,358.3,41299,1,4,0)
 ;;=4^C21.0
 ;;^UTILITY(U,$J,358.3,41299,2)
 ;;=^5000930
 ;;^UTILITY(U,$J,358.3,41300,0)
 ;;=C67.9^^159^2004^111
 ;;^UTILITY(U,$J,358.3,41300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41300,1,3,0)
 ;;=3^Malig Neop Bladder,Unspec
 ;;^UTILITY(U,$J,358.3,41300,1,4,0)
 ;;=4^C67.9
 ;;^UTILITY(U,$J,358.3,41300,2)
 ;;=^5001263
 ;;^UTILITY(U,$J,358.3,41301,0)
 ;;=C71.9^^159^2004^115
 ;;^UTILITY(U,$J,358.3,41301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41301,1,3,0)
 ;;=3^Malig Neop Brain,Unspec
 ;;^UTILITY(U,$J,358.3,41301,1,4,0)
 ;;=4^C71.9
 ;;^UTILITY(U,$J,358.3,41301,2)
 ;;=^5001297
 ;;^UTILITY(U,$J,358.3,41302,0)
 ;;=C18.9^^159^2004^117
